Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 2
2007 2
2014 2
2015 3
2016 4
2017 6
2018 6
2019 3
2020 9
2021 4
2022 7
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Modern Approach to Melanoma Adjuvant Treatment with Anti-PD1 Immune Check Point Inhibitors or BRAF/MEK Targeted Therapy: Multicenter Real-World Report.
Placzke J, Rosińska M, Sobczuk P, Ziętek M, Kempa-Kamińska N, Cybulska-Stopa B, Kamińska-Winciorek G, Bal W, Mackiewicz J, Galus Ł, Las-Jankowska M, Jankowski M, Dziura R, Drucis K, Borkowska A, Świtaj T, Rogala P, Kozak K, Klimczak A, Jagodzińska-Mucha P, Szumera-Ciećkiewicz A, Koseła-Paterczyk H, Rutkowski P. Placzke J, et al. Among authors: kozak k. Cancers (Basel). 2023 Sep 1;15(17):4384. doi: 10.3390/cancers15174384. Cancers (Basel). 2023. PMID: 37686659 Free PMC article.
Tobacco as an efficient metal accumulator.
Kozak K, Antosiewicz DM. Kozak K, et al. Biometals. 2023 Apr;36(2):351-370. doi: 10.1007/s10534-022-00431-3. Epub 2022 Sep 12. Biometals. 2023. PMID: 36097238 Free PMC article. Review.
Long Term Results and Prognostic Biomarkers for Anti-PD1 Immunotherapy Used after BRAFi/MEKi Combination in Advanced Cutaneous Melanoma Patients.
Rogala P, Czarnecka AM, Cybulska-Stopa B, Ostaszewski K, Piejko K, Ziętek M, Dziura R, Rutkowska E, Galus Ł, Kempa-Kamińska N, Seredyńska J, Bal W, Kozak K, Surus-Hyla A, Kubiatowski T, Kamińska-Winciorek G, Suwiński R, Mackiewicz J, Rutkowski P. Rogala P, et al. Among authors: kozak k. Cancers (Basel). 2022 Apr 24;14(9):2123. doi: 10.3390/cancers14092123. Cancers (Basel). 2022. PMID: 35565255 Free PMC article.
Efficacy of immunotherapy beyond RECIST progression in advanced melanoma: a real-world evidence.
Czarnecka AM, Sobczuk P, Rogala P, Świtaj T, Placzke J, Kozak K, Mariuk-Jarema A, Spałek M, Dudzisz-Śledź M, Teterycz P, Borkowska A, Rutkowski P. Czarnecka AM, et al. Among authors: kozak k. Cancer Immunol Immunother. 2022 Aug;71(8):1949-1958. doi: 10.1007/s00262-021-03132-x. Epub 2022 Jan 25. Cancer Immunol Immunother. 2022. PMID: 35075516 Free PMC article.
52 results